Literature DB >> 35181813

Repeat CRS/HIPEC: It Comes Down to Tumor Biology and Ability to Achieve a Complete CRS.

Konstantinos I Votanopoulos1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35181813      PMCID： PMC9115043          DOI： 10.1245/s10434-022-11429-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  13 in total

1.  Personalized Identification of Optimal HIPEC Perfusion Protocol in Patient-Derived Tumor Organoid Platform.

Authors:  Steven D Forsythe; Shyama Sasikumar; Omeed Moaven; Hemamylammal Sivakumar; Perry Shen; Edward A Levine; Shay Soker; Aleksander Skardal; Konstantinos I Votanopoulos
Journal:  Ann Surg Oncol       Date:  2020-07-06       Impact factor: 5.344

2.  Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 cases.

Authors:  Konstantinos I Votanopoulos; Greg Russell; Reese W Randle; Perry Shen; John H Stewart; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2014-10-16       Impact factor: 5.344

3.  Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy.

Authors:  D Elias; F Gilly; F Quenet; J M Bereder; L Sidéris; B Mansvelt; G Lorimier; O Glehen
Journal:  Eur J Surg Oncol       Date:  2010-03-12       Impact factor: 4.424

4.  Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy.

Authors:  Konstantinos I Votanopoulos; Chukwuemeka Ihemelandu; Perry Shen; John H Stewart; Gregory B Russell; Edward A Levine
Journal:  J Am Coll Surg       Date:  2012-05-26       Impact factor: 6.113

5.  Interval between cytoreductions as a marker of tumor biology in selecting patients for repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Authors:  Ioannis T Konstantinidis; Edward A Levine; Konstantinos Chouliaras; Gregory Russell; Perry Shen; Konstantinos I Votanopoulos
Journal:  J Surg Oncol       Date:  2017-06-12       Impact factor: 3.454

6.  Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix.

Authors:  Felipe Lopez-Ramirez; Vadim Gushchin; Michelle Sittig; Mary Caitlin King; Ekaterina Baron; Andrei Nikiforchin; Carol Nieroda; Armando Sardi
Journal:  Ann Surg Oncol       Date:  2022-02-08       Impact factor: 5.344

7.  Incidence, Risk Factors, and Outcomes from Conversion of Low-Grade to High-Grade Appendiceal Neoplasms for Patients Undergoing Multiple Cytoreductive Surgeries with Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Christopher W Mangieri; Cristian D Valenzuela; Richard A Erali; Konstantinos I Votanopoulos; Perry Shen; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2021-08-28       Impact factor: 5.344

8.  Cytoreductive surgery and perioperative intraperitoneal chemotherapy: a new standard of care for appendiceal mucinous tumors with peritoneal dissemination.

Authors:  Paul H Sugarbaker
Journal:  Clin Colon Rectal Surg       Date:  2005-08

9.  Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach.

Authors:  D B Gough; J H Donohue; A J Schutt; N Gonchoroff; J R Goellner; T O Wilson; J M Naessens; P C O'Brien; J A van Heerden
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

10.  Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.

Authors:  Tristan D Yan; Lana Bijelic; Paul H Sugarbaker
Journal:  Ann Surg Oncol       Date:  2007-06-01       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.